Top Markets
Coin of the day
Catalent, Inc. Catalent, Inc.

Catalent, Inc.

CTLT
株式のランク #1926
Catalent, Inc., operating globally through its various subsidiaries,... Catalent, Inc., operating globally through its various subsidiaries, specializes in the development and production of comprehensive solutions for a wide array of products, including pharmaceutical drugs, protein-based biologics, advanced cell and gene therapies, and consumer health items. The company's operations are strategically divided into four key segments: Biologics; Softgel and Oral Technologies; Oral and Specialty Delivery; and Clinical Supply Services. The Softgel and Oral Technologies division focuses on the formulation, development, and manufacturing of soft capsules. These are utilized in a diverse range of client products, such as prescription medications, over-the-counter drugs, nutritional supplements, unit-dose cosmetics, and medicinal preparations for animal health. Within the Biologics segment, Catalent undertakes the creation of biologic cell lines, develops and manufactures both cell therapy and viral-based gene therapy, and handles the formulation and production of parenteral dose forms, including vials, prefilled syringes, and cartridges. This segment also provides essential analytical development and testing capabilities. The Oral and Specialty Delivery segment offers extensive formulation, development, and manufacturing expertise across various technologies. It provides integrated downstream solutions spanning clinical development and commercial supply. This segment also features a dedicated oral delivery solutions platform, encompassing preclinical screening, formulation, analytical development, and current good manufacturing practices (cGMP) services. Finally, the Clinical Supply Services segment delivers vital support for drug and biologic clinical trials. Its services include manufacturing, specialized packaging, secure storage, efficient distribution, and comprehensive inventory management. This segment also offers "FastChain," a demand-led clinical supply service. Catalent serves a broad client base, including pharmaceutical, biotechnology, and consumer health organizations, alongside companies in other healthcare sectors like animal health and medical devices, and even the cosmetics industry. The company was founded in 2007 and maintains its headquarters in Somerset, New Jersey.
株価
$63.48
最終同期: 2024-12-17
時価総額
$11.52B
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Catalent, Inc. (CTLT)

カテゴリー

Bの時価総額のCTLTの価格
Catalent, Inc. Catalent, Inc.
CTLT
$63.48
の時価総額 Catalent, Inc.(CTLT)
時価総額: $11.52B
August 2026時点で、Catalent, Inc. の時価総額は $11.52B です。これは、当社のデータによると、Catalent, Inc. が世界で1926th番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
Catalent, Inc. の時価総額の履歴(2014 から 2026 まで)
CTLT最も人気のあるトップ5と比較stocks
CTLTの価格 資産b bの市場 結果
Catalent, Inc. Catalent, Inc.
$27,838.96 $11.52B
$5.053T +43,754.70%
Catalent, Inc. Catalent, Inc.
$25,146.49 $11.52B
$4.564T +39,513.25%
Catalent, Inc. Catalent, Inc.
$23,114.19 $11.52B
$4.196T +36,311.77%
Catalent, Inc. Catalent, Inc.
$19,993.66 $11.52B
$3.629T +31,396.00%
Catalent, Inc. Catalent, Inc.
$15,543.14 $11.52B
$2.821T +24,385.09%